DIO Corporation
Financials
Valuation Metrics
DIO Corporation's Market Cap is ₩1331B. At end of 2025 it was ₩2266B. Ranked #1092 of 2,421 in KR market (top 45%), #566 of 1,640 on KOSDAQ (top 35%), #37 of 96 in Health Care Equipment & Services (top 39%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 133.09B KRW | KR#1,092/2,421 Sec#37/96 |
| Revenue | 174.45B KRW | KR#1,105/2,421 Sec#16/96 |
| Net Income | 22.10B KRW | KR#667/2,421 Sec#14/96 |
| Total Assets | 327.43B KRW | KR#988/2,421 Sec#21/96 |
| Net Assets | 185.80B KRW | KR#994/2,421 Sec#25/96 |
| Employees | 459 | KR#533/2,421 Sec#10/96 |
| Value | ||
| P/E | 6.02x | KR#455/2,421 Sec#9/96 |
| P/B | 0.72x | KR#1,155/2,421 Sec#25/96 |
| P/S | 0.76x | KR#1,206/2,421 Sec#17/96 |
| EV/EBITDA | 12.12x | KR#723/2,421 Sec#23/96 |
| FCF Yield | 8.83% | KR#650/2,421 Sec#14/96 |
| Profitability | ||
| ROE | 11.90% | KR#480/2,421 Sec#20/96 |
| ROA | 6.75% | KR#543/2,421 Sec#27/96 |
| Op. Margin | 8.09% | KR#651/2,421 Sec#33/96 |
| Revenue Growth | 20.26% | KR#546/2,421 Sec#29/96 |
| Financial Health | ||
| Debt Ratio | 76.23% | KR#1,295/2,421 Sec#72/96 |
| Total Debt | 76.12B KRW | KR#832/2,421 Sec#17/96 |
| FCF | 11.75B KRW | KR#674/2,421 Sec#13/96 |
| Cash | 38.13B KRW | KR#877/2,421 Sec#22/96 |
| Current Ratio | 1.34x | KR#1,333/2,421 Sec#70/96 |
| Net Debt/EBITDA | 2.69x | KR#892/2,421 Sec#36/96 |
| Dividend | ||
| Div. Yield | 2.13% | KR#850/2,421 Sec#20/96 |
| Div. Growth | 56.52% | KR#214/2,421 Sec#12/96 |
| Performance | ||
| 1Y Return | -44.08% | KR#1,928/2,421 Sec#63/96 |
| 1M Return | -16.15% | KR#2,259/2,421 Sec#86/96 |
| From 52W High | -48.87% | KR#1,336/2,421 Sec#42/96 |
| 1Y MDD | -48.60% | KR#929/2,421 Sec#34/96 |
| Trading | ||
| Volume | 39,136 shares | KR#1,251/2,421 Sec#43/96 |
| Trading Value | 387.0M KRW | KR#1,034/2,421 Sec#34/96 |
| Foreign Own. | 14.91% | KR#322/2,421 Sec#8/96 |
| Per Share | ||
| EPS | 1,648 KRW | KR#514/2,421 Sec#11/96 |
| BPS | 13,849 KRW | KR#755/2,421 Sec#11/96 |
Company Info
Established in 1988 to produce automatic packaging machines, DIO was listed on KOSDAQ in 2000 and entered dental implant manufacturing in 2005. The company manufactures and sells medical devices, boasting business partners in over 70 countries through 27 domestic branches and 20 overseas entities. Leveraging technologies such as DIOnavi, DIO secures global superiority and innovates the connectivity across treatment, design, and manufacturing through digital prosthetic solution development and AI convergence research. DIO is headquartered in Haeundae-gu, Busan Metropolitan City.